Cargando…
Testosterone treatment improves liver function and reduces cardiovascular risk: A long-term prospective study
Objectives: To report the association between testosterone treatment in hypogonadal men with hepatic steatosis, non-alcoholic fatty liver disease and cardiovascular disease (CVD). Methods: A prospective study was conducted to assess the physiological and functional performance of the long-term effec...
Autores principales: | Al-Qudimat, Ahmad, Al-Zoubi, Raed M., Yassin, Aksam A., Alwani, Mustafa, Aboumarzouk, Omar M., AlRumaihi, Khaled, Talib, Raidh, Al Ansari, Abdulla |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8451678/ https://www.ncbi.nlm.nih.gov/pubmed/34552789 http://dx.doi.org/10.1080/2090598X.2021.1959261 |
Ejemplares similares
-
The impact of long-term Testosterone Therapy (TTh) in renal function (RF) among hypogonadal men: An observational cohort study
por: Alwani, Mustafa, et al.
Publicado: (2021) -
Cardiovascular Disease, Hypogonadism and Erectile Dysfunction: Early Detection, Prevention and the Positive Effects of Long-Term Testosterone Treatment: Prospective Observational, Real-Life Data
por: Alwani, Mustafa, et al.
Publicado: (2021) -
A systematic review on the latest developments in testosterone therapy: Innovations, advances, and paradigm shifts
por: Al-Zoubi, Raed M., et al.
Publicado: (2021) -
Voiding function improves under long-term testosterone treatment (TTh) in hypogonadal men, independent of prostate size
por: Yassin, Aksam, et al.
Publicado: (2023) -
Testosterone and Covid‐19: An update
por: Yassin, Aksam, et al.
Publicado: (2022)